The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Uncomplicated Urinary Tract Infections: Developing Drugs for Treatment.'' The purpose of this draft guidance is to assist sponsors in the development of new drugs for the treatment of uncomplicated urinary tract infections.
Document
Uncomplicated Urinary Tract Infections: Developing Drugs for Treatment; Draft Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Uncomplicated Urinary Tract Infections: Developing Dr...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 21784
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Uncomplicated Urinary Tract Infections: Developing Drugs for Treatment; Draft Guidance for Industry; Availability,” thefederalregister.org (May 10, 2018), https://thefederalregister.org/documents/2018-09929/uncomplicated-urinary-tract-infections-developing-drugs-for-treatment-draft-guidance-for-industry-availability.